Resource Listing
WEBSITE
Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study
Piedimonte S, Helpman L, Pond G, Nelson G, Kwon J, Altman A, Feigenberg T, Elit L, Lau S, Sabourin J, Samouelian V, Willows K, Aubrey C, Jang J-H, Teo-Fortin L-A, Cockburn N, Saunders N-B, Shamiya S, Vicus D, Plante M, Collaborative OBOTCCCC. Gynecologic Oncology. 2023 May 3;174:21-27.
WEBSITE
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial
Goldberg M, Parpia S, Rakovitch E, Chang L, Bowen J, Lukka H, Perera F, Fyles A, Wright J, Sussman J, Whelan T. Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial. The Breast. 2023 April; 68. 189-193.
WEBSITE
Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition
Chan SWS, Shukla R, Ramsay J, McWhirter E, Barnfield P, Juergens RA. Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition. Current Oncology. 2023 April; 30(5):4527-4537.
WEBSITE
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
Shayegan B, Wallis CJD, Hamilton RJ, Morgan SC, Cagiannos I, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Park-Wyllie L, Chan KFY, Malone S. Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada. Prostate Cancer and Prostatic Disease. 2023 Mar; 26(1) 74-79
WEBSITE
Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study
Donovan EK, Pond GR, Seow H, Ellis PM, Swaminath A. Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study. Clin Oncol (R Coll Radiol). 2023 Feb;35(2):e182-e188. doi: 10.1016/j.clon.2022.11.019. Epub 2022 Dec 17.
WEBSITE
Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer
Gouran-Savadkoohi M, Mesci A, Pond GR, Swaminath A, Quan K, Wright J, Tsakiridis T. Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer. J Thorac Dis. 2023 Feb 28;15(2):423-433
WEBSITE
A double-blinded, randomized trial comparing surgeon-administered transversus abdominis plane block with placebo after midline laparotomy in gynecologic oncology surgery
Bernard L, Lavecchia M, Trepanier G, Mah S, Pokoradi A, McGinnis JM, Alyafi M, Glezerson B, Nguyen J, Carlson V, Helpman L, Elit L, Jimenez W, Eiriksson L, Reade CJ. A double-blinded, randomized trial comparing surgeon-administered transversus abdominis plane block with placebo after midline laparotomy in gynecologic oncology surgery. Am J Obstet Gynecol. 2023 May;228(5):553.e1-553.e8.
WEBSITE
Very low energy diets prior to bariatric surgery may reduce postoperative morbidity: a systematic review and meta-analysis of randomized controlled trials
McKechnie T, Lee Y, Dionne J, Doumouras A, Parpia S, Bhandari M, Eskicioglu C. Very low energy diets prior to bariatric surgery may reduce postoperative morbidity: a systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2023 Jun 20;10:1211575.
WEBSITE
A Cancer Care Ontario Consensus-Based Organizational Guideline for the Planning and Delivery of Spine Stereotactic Body Radiation Therapy Treatment in Ontario
Sahgal A, Kellett S, Nguyen T, Maralani P, Greenspoon J, Linden K, Pearce A, Siddiqi F, Ruschin M; Spine Expert Panel. A Cancer Care Ontario Consensus-Based Organizational Guideline for the Planning and Delivery of Spine Stereotactic Body Radiation Therapy Treatment in Ontario. Pract Radiat Oncol. 2023 Nov-Dec;13(6):499-509.
WEBSITE
Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
Lee WR, Dignam JJ, Amin M, Bruner DW, Low D, Swanson GP, et al. Long-term follow-up analysis of nrg oncology rtog 0415: a randomized phase iii non-inferiority study comparing two fractionation schedules in patients with favorable-risk prostate cancer. International Journal of Radiation Oncology. 2023 Oct 1 ;117(2):S3–4.
WEBSITE
Teclistamab in Relapsed or Refractory Multiple Myeloma
Cliff E, Mian H, Mohyuddin G. N Engl J Med. 2022 Nov 3;387(18):1721-1722.
WEBSITE
MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer
Turco C, Esposito G, Iaiza A, Goeman F, Benedetti A, Gallo E, Daralioti T, Perracchio L, Sacconi A, Pasanisi P, Muti P, Pulito C, Strano S, Ianniello Z, Fatica A, Forcato M, Fazi F, Blandino G, Fontemaggi G. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. Communications Biology. 2022 Jun; 5(1): 598
WEBSITE
Quality of end?of?life care in multiple myeloma: A 13?year analysis of a population?based cohort in Ontario, Canada
Mohyuddin GR, Sinnarajah A, Gayowsky A, Chan KKW, Seow H, Mian H. Quality of end?of?life care in multiple myeloma: A 13?year analysis of a population?based cohort in Ontario, Canada. British Journal of Haematology. 2022 Dec;199(5):688-695.
WEBSITE
Desmoplastic small round cell tumor involving the uterine cervix: The first reported case in the literature, and brief review of gynecologic presentations
Kapoor R, Sur M, Kagoma YK, Schnarr K, Zbuk K, Nguyen JMV. Desmoplastic small round cell tumor involving the uterine cervix: The first reported case in the literature, and brief review of gynecologic presentations. Gynecol Oncol Rep. 2022 Oct 7;44:101079.
WEBSITE
The status of surgical margins in relation to the type of surgical approach in the management of early-stage cervical cancer: Canadian Cervical Cancer Collaborative (4C) study (533)
The status of surgical margins in relation to the type of surgical approach in the management of early-stage cervical cancer: Canadian Cervical Cancer Collaborative (4C) study (533). Gynecologic Oncology. 2022 Aug; 166;261
WEBSITE
A new platform for post-marketing surveillance and real-world evidence data collection for substance-based medical devices
Cioeta R, Cossu A, Giovagnoni E, Rigoni M, Muti P. A new platform for post-marketing surveillance and real-world evidence data collection for substance-based medical devices. Frontiers in Drug Safety and Regulation. 2022. 2;992359
WEBSITE
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population
Millan B, Breau RH, Mallick R, Wood L, Rendon R, Finelli A, So AI, Lavallée LT, Pouliot F, Bhindi B, Heng D, Drachenberg D, Tanguay S, Dean L, Basappa NS, Lattouf J-B, Bjarnason G, Lalani A-K, Kapoor A. Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population. Urologic Oncology Seminars and Original Investigations. 2023 May 16;S1078-1439(23)00133-3.
WEBSITE
Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis
Aghel N, Lui M, Wang V, Khalaf D, Mian H, Hillis C, Walker I, Leber B, Lipton JH, Aljama M, Lepic K, Berg T, Garcia-Horton A, Petropoulos J, Masoom H, Leong DP. Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis. Bone Marrow Transplantation. 2023 May; 58(5) 478-490
WEBSITE
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Catenacci DV, Kang Y-K, Uronis HE, Lee K-W, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song E-K, Chee CE, Chao Y, Kim S, Oh D-Y, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. Oncology. 2023 April; 37(4):176-183.
WEBSITE
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539
Rogers CL, Pugh SL, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Barani IJ, Braunstein S, Bovi JA, de Groot JF, Whitton AC, Lindhorst SM, Deb N, Shrieve DC, Shu H-K, Bloom B, Machtay M, Mishra MV, Robinson CG, Won M, Mehta MP. Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. Neuro-Oncology. 2023 Jan; 25(1): 137-145
WEBSITE
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Beltran-Bless AA, Clemons MJ, Fesl C, Greil R, Pond GR, Balic M, Vandermeer L, Bjelic-Radisic V, Singer CF, Steger GG, Helfgott R, Egle D, Sölkner L, Gampenrieder SP, Kacerovsky-Strobl S, Suppan C, Ritter M, Rinnerthaler G, Pfeiler G, Fohler H, Hlauschek D, Hilton J, Gnant M. Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12. Eur J Cancer. 2023 Feb;180:108-116.
WEBSITE
Optimizing Cancer Survivorship Care: Examination of Factors Associated with Transition to Primary Care
Mukherjee SD, Bainbridge D, Hillis C, Sussman J. Optimizing Cancer Survivorship Care: Examination of Factors Associated with Transition to Primary Care. Curr Oncol. 2023 Feb 24;30(3):2743-2750.
WEBSITE
A scoping review of natural language processing of radiology reports in breast cancer
Saha A, Burns L, Kulkarni AM. A scoping review of natural language processing of radiology reports in breast cancer. Front Oncol. 2023 Apr 12;13:1160167. d
WEBSITE
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma
Labaki C, Saliby RM, Bakouny Z, Saad E, Semaan K, Eid M, Lalani AK, Choueiri TK, Braun DA. Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma. Hematol Oncol Clin North Am. 2023 Oct;37(5):937-942. doi: 10.1016/j.hoc.2023.05.021. Epub 2023 Jul 3. PMID: 37407357.
WEBSITE
An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study
Pfisterer KJ, Lohani R, Janes E, Ng D, Wang D, Bryant-Lukosius D, Rendon R, Berlin A, Bender J, Brown I, Feifer A, Gotto G, Saha S, Cafazzo JA, Pham Q. An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study. JMIR Cancer. 2023 Oct 4;9:e44332.
WEBSITE
Disease control outcomes of stereotactic body radiation therapy or moderate hypo?fractionation for prostate cancer: Real?world experience at two Canadian centers
Hu H, Anagnostopoulos G, Gouran?Savadkoohi M, Dayes I, Ishkanian A, Hallock A, et al. Disease control outcomes of stereotactic body radiation therapy or moderate hypo?fractionation for prostate cancer: Real?world experience at two Canadian centers. The Prostate . 2024 Feb;84(2):193–202.
WEBSITE
A Systematic Literature Review of Health Utility Values in Breast Cancer
Kaur MN, Yan J, Klassen AF, David JP, Pieris D, Sharma M, Bordeleau L, Xie F. A Systematic Literature Review of Health Utility Values in Breast Cancer. Medical Decision Making. 2022 July; 42(5) 704-719
WEBSITE
Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis
Cirne F, Kappel C, Zhou S, Mukherjee SD, Dehghan M, Petropoulos J-A, Leong DP. Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis. Prostate Cancer and Prostatic Disease. 2022 Sep; 25(3): 453-462
WEBSITE
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA, investigators BTT. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study. The Lancet. 2022 Aug 6;400(10350):431-440.
WEBSITE
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial
Swaminath A, Wierzbicki M, Parpia S, Kundapur V, Faria S, Ahmed N, Bujold A, Hirmiz K, Owen T, Leong N, Ramchandar K, Filion E, Lau H, Thompson R, Yaremko B, Gabos Z, Mehiri S, Wright JR, Tsakiridis TK, Cline K, Whelan TJ. Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial. Clin Transl Radiat Oncol. 2022 Oct 13;37:145-152.
WEBSITE
Germline BRCA mutations are associated with an increased likelihood of secondary cytoreductive surgery in ovarian cancer patients (116)
Yfat K, Mariam K, Mario B, Hal H, Dana J, Lina S, Ilan B, Gregory P, Limor H. Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer. Gynecol Oncol. 2022 Sep 22:S0090-8258(22)00574-1.
WEBSITE
Effectiveness and tolerability of Poliprotect, a natural mucosal protective agent for gastroesophageal reflux disease and dyspepsia: Surveys from patients, physicians, and pharmacists
Cioeta R, Muti P, Rigoni M, Morlando L, Siragusa F, Cossu A, Giovagnoni E. Effectiveness and tolerability of Poliprotect, a natural mucosal protective agent for gastroesophageal reflux disease and dyspepsia: Surveys from patients, physicians, and pharmacists. Frontiers in Drug Safety and Regulation. 2022 Oct; 2; 959831
WEBSITE
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort study
Visram A, Seow H, Fiala MA, Gayowsky A, Cheung M, Davies G, Pond GR, Mian H. American Journal of Hematology. Am J Hematol. 2023;1–3.
WEBSITE
Impact of Second Primary Malignancy Post-Autologous Transplantation on Outcomes of Multiple Myeloma: A CIBMTR Analysis
Ragon BK, Shah MV, D’Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Hadidi SA, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. Impact of Second Primary Malignancy Post-Autologous Transplantation on Outcomes of Multiple Myeloma: A CIBMTR Analysis. Blood Advances. 2023 June; 7(12) 2746-2757.
WEBSITE
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multi-Centre Open-Label Phase 3 Trial
Behroozian T, Milton L, Karam I, Zhang L, Ding K, Lou J, Gallant F, Rakovitch E, Tran W, Soliman H, Leung E, Vesprini D, Szumacher E, Chen H, Donovan E, Lam J, Spadafora S, Wronski M, Lavoie C, Walde N, Lam E, Wong G, McKenzie E, Ariello K, Kennedy S, Shariati S, Carothers K, Gonzales G, Kaga Y, Chow E. Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multi-Centre Open-Label Phase 3 Trial. Journal of Medical Imaging and Radiation. 2023 April; 54(1) :2-3.
WEBSITE
Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada
Robinson C, Schlorff M, Chanchlani R, Gayowsky A, Darling E, Mondal T, Seow H, Batthish M. Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada. Pediatric Cardiology. 2023 Mar;44(3):681-688.
WEBSITE
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)
Rosenberg JE, Park SH, Kozlov V, Dao TV, Castellano D, Li JR, Mukherjee SD, Howells K, Dry H, Lanasa MC, Stewart R, Bajorin DF. Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). J Clin Oncol. 2023 Jan 1;41(1):43-53.
WEBSITE
A Competition, Benchmark, Code, and Data for Using Artificial Intelligence to Detect Lesions in Digital Breast Tomosynthesis
Konz N, Buda M, Gu H, Saha A, Yang J, Chledowski J, Park J, Witowski J, Geras KJ, Shoshan Y, Gilboa-Solomon F, Khapun D, Ratner V, Barkan E, Ozery-Flato M, Martí R, Omigbodun A, Marasinou C, Nakhaei N, Hsu W, Sahu P, Hossain MB, Lee J, Santos C, Przelaskowski A, Kalpathy-Cramer J, Bearce B, Cha K, Farahani K, Petrick N, Hadjiiski L, Drukker K, Armato SG 3rd, Mazurowski MA. A Competition, Benchmark, Code, and Data for Using Artificial Intelligence to Detect Lesions in Digital Breast Tomosynthesis. JAMA Netw Open. 2023 Feb 1;6(2):e230524.
WEBSITE
Location of death among children with life-threatening conditions: a national population-based observational study using the Canadian Vital Statistics Database (2008–2014)
Widger K, Brennenstuhl S, Tanuseputro P, Nelson KE, Rapoport A, Seow H, Siden H, Vadeboncoeur C, Gupta S. Location of death among children with life-threatening conditions: a national population-based observational study using the Canadian Vital Statistics Database (2008-2014). CMAJ Open. 2023 Apr 4;11(2):E298-E304.
WEBSITE
A pilot study of adherence to lenalidomide among older patients with multiple myeloma
Silberstein AE, Fiala MA, Loh KP, Cordner T, Mian H, Wildes TM. A pilot study of adherence to lenalidomide among older patients with multiple myeloma. J Geriatr Oncol. 2023 Sep;14(7):101560.
WEBSITE
A history of bariatric surgery before surgery for colorectal cancer may improve short-term postoperative outcomes: Analysis of the national inpatient sample 2015–2019
McKechnie T, Lee Y, Hong D, Dionne J, Doumouras A, Parpia S, Bhandari M, Eskicioglu C. A history of bariatric surgery before surgery for colorectal cancer may improve short-term postoperative outcomes: Analysis of the national inpatient sample 2015–2019. Surgery. 20203 Nov; 174(5): 1168-1174
WEBSITE
What’s New in Musculoskeletal Tumor Surgery.
Gazendam A, Ghert M. What's New in Musculoskeletal Tumor Surgery. J Bone Joint Surg Am. 2023 Dec 20;105(24):1929-1936.
WEBSITE
Prophylaxis extension for venous thromboembolism after major abdominal and pelvic surgery for cancer (prevent): Quality improvement transitioned into a cohort study
McKechnie T, Tywonek K, Simunovic M, Serrano PE. Prophylaxis extension for venous thromboembolism after major abdominal and pelvic surgery for cancer (prevent): Quality improvement transitioned into a cohort study. Surgery. 2022 July; 172(1) 234-240
WEBSITE
Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC)
Donovan EK, Xie F, Louie AV, Chu W, Siva S, Kapoor A, Swaminath A. Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC). Clinical Genitourinary Cancer. 2022 Oct; 20(5):e353-e361
WEBSITE
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial
Muti P, Sacconi A, Pulito C, Orlandi G, Donzelli S, Morrone A, Jiulian J, Cox GP, Kolb M, Pond G, Kavsak P, Levine MN, Blandino G, Strano S. Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial. Journal of Experimental & Clinical Cancer Research. 2022 Aug 20;41(1):255.
WEBSITE
Examining patient perspectives on sarcoma surveillance: The Sarcoma Surveillance Survey
Tepper SC, Holten AK, Jeffe DB, England PH, Hong ZL, Pérez M, Ghert M, Hirbe AC, Cipriano CA. Examining patient perspectives on sarcoma surveillance: The Sarcoma Surveillance Survey. Surg Oncol. 2022 Dec;45:101861
WEBSITE
First Pan-Canadian Consensus Recommendations for Proton Beam Therapy Access in Canada
Mitera G, Tsang D, McCurdy B, Goddard K, Ebacher A, Craig T, Greenland J, Kentish S, Koul R, Logie N, Morneau M, Morrison A, Pan L, Pantarotto J, Foxcroft S, Sussman J, Thompson R, Tyldesley S, Wright P, Hicks S, Brown E, Patel S; CAPCA pan-Canadian PBT Working Group. Pan-Canadian consensus recommendations for proton beam therapy access in Canada. Radiother Oncol. 2022 Nov;176:228-233. doi: 10.1016/j.radonc.2022.10.004. Epub 2022 Oct 11. PMID: 36228758.
WEBSITE
Improvement of type 2 diabetes in a bipolar patient after initiation of atypical antipsychotic therapy.
Claro AE, Palanza C, Mazza M, Rizzi A, Tartaglione L, Marano G, Muti Schuenemann GE, Rigoni M, Muti P, Pontecorvi A, Janiri L, Sani G, Pitocco D. Improvement of type 2 diabetes in a bipolar patient after initiation of atypical antipsychotic therapy. Minerva Endocrinol (Torino). 2022 Aug 1.
WEBSITE
Development and Validation of an Indicator for Oncofertility Care in Ontario, Canada, for Adolescents and Young Adults with Cancer
Rae CS, Barr RD, Seow H, Costa A. Journal of Adolescent and Young Adult Oncology. J Adolesc Young Adult Oncol. 2023 May 5.
WEBSITE
Heterogeneity across outcomes reported in clinical trials for older adults with depression: a systematic survey
Rodrigues M, Syed Z, Dufort A, Sanger N, Ghiassi P, Sanger S, Panesar B, D'Elia A, Parpia S, Samaan Z, Thabane L. Heterogeneity across outcomes reported in clinical trials for older adults with depression: a systematic survey. Journal of Clinical Epidemiology. 2023 May; 157 59-73.
WEBSITE
Detection of macrotroponin in patients receiving treatment for breast cancer
Kavsak PA, Hoard B, Mackett K, Mukherjee SD, Bordeleau L, Ellis PM, Dhesy-Thind S.Detection of macrotroponin in patients receiving treatment for breast cancer. CJC Open. 2023 May; 5(8)
WEBSITE
Real?world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database
Mian H, LeBlanc R, Louzada M, Masih?Khan E, McCurdy A, Venner CP, Stakiw J, Kardjadj M, Jimenez?Zepeda VH, Sebag M, White D, Aslam M, Song K, Reiman A, Kotb R, Gul E, Reece D. Real?world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database. Cancer Medicine. 2023 Feb;12(4):4357-4362..
WEBSITE
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, Eng C, Pal T, Cullinane CA, Couch FJ, Kotsopoulos J, Sun P, Lubinski J, Narod SA. The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cancer. 2023 Mar 15;129(6):901-907
WEBSITE
Medical emergencies in dental practice: A nationwide web-based survey of Italian dentists
Varoni EM, Rigoni M, Lodi G, Sardella A, Muti P, Vitello A, Montebugnoli L, Polimeni A, Tommasino S, Iriti M, Senna A, Iandolo R, Nisio A, Carrassi A. Medical emergencies in dental practice: A nationwide web-based survey of Italian dentists. Heliyon. 2023 Feb 23;9(3):e13910.
WEBSITE
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials
Hallemeier CL, Moughan J, Haddock MG, Herskovic AM, Minsky BD, Suntharalingam M, Zeitzer KL, Garg MK, Greenwald BD, Komaki RU, Puckett LL, Kim H, Lloyd S, Bush DA, Kim HE, Lad TE, Meyer JE, Okawara GS, Raben A, Schefter TE, Barker JL Jr, Falkson CI, Videtic GMM, Jacob R, Winter KA, Crane CH. Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials. JAMA Netw Open. 2023 Apr 3;6(4):e238504.
WEBSITE
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
Boutin M, Topham JT, Feilotter H, Kennecke HF, Couture F, Harb M, Kavan P, Berry S, Lim HJ, Goffin JR, Ahmad C, Lott A, Renouf DJ, Jonker DJ, Tu D, O'Callaghan CJ, Chen EX, Loree JM. Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer. Ther Adv Med Oncol. 2023 Jun 22;15:17588359231183682.
WEBSITE
Evaluating equity of access and predictors of minimally invasive hysterectomy for endometrial and cervical cancer from 2000 to 2017 in Ontario, Canada: A population?based cohort study
McGinnis JM, Pond GR, Reade CJ, Schnarr KL, Simunovic M, Elit LM, Seow HY, Helpman L. Evaluating equity of access and predictors of minimally invasive hysterectomy for endometrial and cervical cancer from 2000 to 2017 in Ontario, Canada: A population-based cohort study. J Surg Oncol. 2023 Sep 26.
WEBSITE
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
Tombari C, Zannini A, Bertolio R, Pedretti S, Audano M, Triboli L, et al. Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth. Nat Commun. 2023 Oct 25;14(1):6777
WEBSITE
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
Nguyen EK, Lalani AKA, Ghosh S, Basappa NS, Kapoor A, Hansen AR, Kollmannsberger C, Heng D, Wood LA, Castonguay V, Soulières D, Winquist E, Canil C, Graham J, Bjarnason GA, Breau RH, Pouliot F, Swaminath A. Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. Advances in Radiation Oncology. 2022 July; 7(4) 100899
WEBSITE
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada
Selvarajah S, Schrader KA, Kolinsky MP, Rendon RA, El Hallani S, Fleshner NE, Hotte SJ, Lorentz J, Panabaker K, Perrier R, Pouliot F, Spatz A, Yip S, Chi KN. Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada. Canadian Urological Association Journal. 2022 Nov; 16(11): e516-e522
WEBSITE
ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas—Does Timing Impact Complication Rates?
Gazendam AM, Schneider P, Spiguel A, Ghert M. ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas—Does Timing Impact Complication Rates. Annals of Surgical Oncology. 2022 Nov;29(12):7319.
WEBSITE
Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Clinical Practice Guideline
Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Clinical Practice Guideline. J Thorac Oncol. 2022 Nov;17(11):1258-1275
WEBSITE
Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients?
Levin BA, Lama DJ, Sussman J, Guan T, Rao M, Tobler J, Verma S, Sidana A. Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients? Aging Male. 2022 Dec;25(1):23-28.
WEBSITE
Racial Disparities in Patients with Stage IIIC Endometrial Cancer
Patrich T, Wang Y, Elshaikh MA, Zhu S, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino JP, Russo AL, Lea JS, Lee LJ, Albuquerque K, Hathout L. Racial Disparities in Patients with Stage IIIC Endometrial Cancer. International Journal of Radiation Oncology. Nov 2023; 114(3);s273-s274
WEBSITE
Building Palliative Care Capacity for Generalist Providers in the Community: Results From the Capaciti Pilot Education Program
Seow H, Bainbridge D, Stajduhar K, Marshall D, Howard M, Brouwers M, Barwich D, Burge F, Kelley ML. Building Palliative Care Capacity for Generalist Providers in the Community: Results From the Capaciti Pilot Education Program. American Journal of Hospice and Palliative Medicine. 2023 July; 40(7) 737-746.
WEBSITE
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Lukka HR, Deshmukh S, Bruner DW, Bahary J-P, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Feng FY, Pugh SL, Sandler HM, Kachnic LA. Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. International Journal of Radiation Oncology. 2023 July; 116(4) 770-778.
WEBSITE
Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer.
Dayes IS, Metser U, Hodgson N, Parpia S, Eisen AF, George R, Blanchette P, Cil TD, Arnaout A, Chan A, Levine MN. Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer. Journal of Clinical Oncology 2023 May. 41(23).
WEBSITE
A Meta-Analysis of Trials of Partial Breast Irradiation
Goldberg M, Bridhikitti J, Khan AJ, McGale P, Whelan TJ. A Meta-Analysis of Trials of Partial Breast Irradiation. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):60-72.
WEBSITE
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry
Buckstein R, Chodirker L, Yee KWL, Geddes M, Leitch HA, Christou G, Banerji V, Leber B, Khalaf D, St-Hilaire E, Finn N, Nevill T, Keating MM, Storring J, Parmentier A, Thambipillai A, Tang D, Westcott C, Cameron C, Spin P. The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leuk Lymphoma. 2023 Mar;64(3):651-661.
WEBSITE
Outcome measures in palliative care training interventions: a systematic review of trial-based studies
Seow H, Bishop VC, Myers J, Stajduhar KI, Marshall DI, Incardona NK, Levine OH, Steinberg LJ, Bainbridge DB. Outcome measures in palliative care training interventions: a systematic review of trial-based studies. Ann Palliat Med. 2023 Mar;12(2):399-417
WEBSITE
Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study.
Kwan EM, Rushton MK, Tu W, Hotte SJ, Mukherjee SD, Ong M, Kolinsky MP, Hamilou Z, Winquist E, Ferrario C, Macfarlane RJ, Saad F, Salim M, Jiang DM, Tu D, Hutchenreuther J, Annala M, Seymour L, Chi KN, Wyatt AW. Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study. Journal of Clinical Oncology. 2023 Oct: 41(6) 2:218
WEBSITE
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
Renouf DJ, Loree JM, Knox JJ, Topham JT, Kavan P, Jonker D, Welch S, Couture F, Lemay F, Tehfe M, Harb M, Aucoin N, Ko Y-J, Tang PA, Ramjeesingh R, Meyers BM, Kim CA, Du P, Jia S, Schaeffer DF, Gill S, Tu D, O’Callaghan CJ. The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma. Nature Communications. 2022 Aug:
WEBSITE
Long-Term Toxicity in Patients Receiving Radiotherapy for Ultracentral Stage I Non-Small Cell Lung Cancer – A Secondary Analysis of the LUSTRE Randomized Trial
Wu CHD, Wierzbicki M, Parpia S, Kundapur V, Bujold A, Filion EJ, et al. Long-term toxicity in patients receiving radiotherapy for ultracentral stage i non-small cell lung cancer – a secondary analysis of the lustre randomized trial. International Journal of Radiation Oncology. 2023 Oct 1 ;117(2) s171
WEBSITE
Omitting Radiotherapy in Luminal A Breast Cancer
Recht A. Omitting Radiotherapy in Luminal A Breast Cancer. N Engl J Med. 2023 Nov 2;389(18):1727.
WEBSITE
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
Voon PJ, Chen EX, Chen HX, Lockhart AC, Sahebjam S, Kelly K, Vaishampayan UN, Subbiah V, Razak AR, Renouf DJ, Hotte SJ, Singh A, Bedard PL, Hansen AR, Ivy SP, Wang L, Stayner L-A, Siu LL, Spreafico A. Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. Journal of Experimental & Clinical Cancer Research. 2022 Dec; 41(1) 51
WEBSITE
Disparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada
Jackson EB, Hotte SJ. Disparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada. Canadian Urological Association Journal. 2022 Nov; 16(11):E516-E522
WEBSITE
Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer
Sharma A, Searle K, Hasan S, Chan S, Pond G, Jerzak KJ. Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer. Clinical Breast Cancer. 2022 Oct;22(7):629-633
WEBSITE
An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership
Lynch C, Harrison S, Butler J, Baldwin DR, Dawkins P, van der Horst J, Jakobsen E, McAleese J, McWilliams A, Redmond K, Swaminath A, Finley CJ. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership. Cancer Control. 2022 Jan-Dec;29:107327
WEBSITE
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
Teichman J, Geddes M, Zhu N, Keating MM, Sabloff M, Christou G, Leber B, Khalaf D, St-Hilaire E, Finn N, Shamy A, Yee KWL, Storring JM, Nevill TJ, Delage R, Elemary M, Banerji V, Houston B, Mozessohn L, Chodirker L, Zhang L, Siddiqui M, Parmentier A, Leitch HA, Buckstein RJ. High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes. Haematologica. 2023 Feb 1;108(2):532-542.
WEBSITE
Development of a Support Vector Machine-Based Tool for Survival Prediction after Stereotactic Body Radiotherapy for Liver Metastases Using Multi-Institutional Data
Nam K, Arsenault T, Baydoun A, Amini A, Saieed G, Zeidane RA, Bhat SS, Bailey L, Sachdeva R, Chow R, Chu W, Liu H, Chung HT, Schellenberg D, Swaminath A, Lock MI, Podder TK, Biswas T.Development of a Support Vector Machine-Based Tool for Survival Prediction after Stereotactic Body Radiotherapy for Liver Metastases Using Multi-Institutional Data. International Journal of Radiation Oncology. 2022 Nov: 114(3): e1222
WEBSITE
Identifying Very-Low-Risk Patients for Future Myocardial Infarction or Death
Kavsak PA, Cerasuolo JO, Hewitt MK, Mondoux SE, Perez R, Seow H, Ainsworth C, Ma J, Worster A, Ko DT. Identifying Very-Low-Risk Patients for Future Myocardial Infarction or Death. Canadian Journal of Cardiology. 2023 April; 39(4) 527-530.
WEBSITE
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
Wong JK, Lim HJ, Tam VC, Burak KW, Dawson LA, Chaudhury P, Abraham RJ, Meyers BM, Sapisochin G, Valenti D, Samimi S, Ramjeesingh R, Mujoomdar A, Martins I, Dixon E, Segedi M, Liu DM. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews. 2023 APril; 115 102-526.
WEBSITE
Factors Associated With Adolescent and Young Adult Females Attending a Fertility Consultation Within 30 Days of a Cancer Diagnosis in Ontario, Canada
Rae CS, Costa A, Seow H, Barr RD. Factors Associated With Adolescent and Young Adult Females Attending a Fertility Consultation Within 30 Days of a Cancer Diagnosis in Ontario, Canada. Journal of Adolescent and Young Adult Oncology. 2023 June.
WEBSITE
Evaluation of the prevalence of the most common psychiatric disorders in patients with type 2 diabetes mellitus using the patient health questionnaire: results of the cross-sectional “DIA2PSI” study
Claro AE, Palanza C, Mazza M, Corsello A, Rizzi A, Tartaglione L, de Waure C, Marano G, Piciollo S, Muti Schuenemann GEU, Rigoni M, Muti P, Pontecorvi A, Janiri L, Sani G, Pitocco D. Evaluation of the prevalence of the most common psychiatric disorders in patients with type 2 diabetes mellitus using the patient health questionnaire: results of the cross-sectional "DIA2PSI" study. Acta Diabetol. 2023 Feb;60(2):247-255.
WEBSITE
Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial
Petrovic B, Julian JA, Liddy C, Afkham A, McGee SF, Morgan SC, Segal R, Sussman J, Pond GR, O'Brien MA, Bender JL, Grunfeld E. Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial. J Med Internet Res. 2023 Jan 18;25:e40725.
WEBSITE
Recent Advances in Optimizing Radiation Therapy Decisions in Early Invasive Breast Cancer
Riaz N, Jeen T, Whelan TJ, Nielsen TO. Recent Advances in Optimizing Radiation Therapy Decisions in Early Invasive Breast Cancer. Cancers (Basel). 2023 Feb 16;15(4):1260.
WEBSITE
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Lalani AA, Kapoor A, Basappa NS, Bhindi B, Bjarnason GA, Bosse D, Breau RH, Canil CM, Cardenas LM, Castonguay V, Chavez-Munoz C, Chu W, Dudani S, Graham J, Heng DYC, Kollmannsberger C, Lattouf JB, Morgan S, Reaume MN, Richard PO, Swaminath A, Tanguay S, Wood LA, Lavallée LT. Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement. Can Urol Assoc J. 2023 May;17(5):E154-E163.
WEBSITE
Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region.
Kisiel M, Reddy KKV, Provias J, Whitton AC, Lu JQ. Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region. Clin Neuropathol. 2023 Jun 29.
WEBSITE
Treatment Modalities to Manage Hepatocellular Carcinoma Patients with Portal Vein Thrombus: A Systematic Review and Meta-Analysis
Liu B, Grindrod N, Meyers BM, Freiburger S, Boldt G, Malik A, Jairam MP, Brahmania M, Cardarelli Leite L, Simone CB 2nd, Chow R, Lock M. Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysis. Ann Palliat Med. 2023 Nov;12(6):1165-1174.
WEBSITE
Protocol for a longitudinal cohort study of Lyme disease with physical, mental and immunological assessment
Loeb M, Brison R, Bramson J, Hatchette T, Sander B, Stringer E. Protocol for a longitudinal cohort study of Lyme disease with physical, mental and immunological assessment. BMJ Open. 2023 Nov 2;13(11):e076833
WEBSITE
Salvage radiotherapy following HiFU: An institutional series and literature review
Mesci A, Gouran?Savadkoohi M, Ribeiro D, Dayes I, Lukka H, Schnarr K, Quan K, Goldberg M, Hallock A, Tsakiridis T. Salvage radiotherapy following HiFU: An institutional series and literature review. Journal of Medical Imaging and Radiation. 2022 Sept; 6(6) 847-852
WEBSITE
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada
Hillis C, Vicente C, Ball G. The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada. PharmacoEconomics. 2022 Sep;40(9):917-928
WEBSITE
Study protocol for assessing knowledge, attitudes and belief towards HPV vaccination of parents with children aged 9–14 years in rural communities of North West Cameroon: a qualitative study
Elit L, Ngalla C, Afugchwi GM, Tum E, Fokom-Domgue J, Nouvet E. Study protocol for assessing knowledge, attitudes and belief towards HPV vaccination of parents with children aged 9–14 years in rural communities of North West Cameroon: a qualitative study. BMJ Open. 2022 Aug 24;12(8):e062556.
WEBSITE
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis
Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol. 2022 Dec 1;8(12):1809-1815.
WEBSITE
Radiation Dose, Technique and Use of Brain Radiation on Overall Survival in Patients with Limited-Stage Small Cell Lung Cancer
Palchik S, Pond G, Wu CHD, Wright J, Tsakiridis T, Swaminath A. Radiation Dose, Technique and Use of Brain Radiation on Overall Survival in Patients with Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology. 2022 Nov;114(3);e411
WEBSITE
Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney)
Siva S, Correa RJM, Ali M, Muacevic A, Ponsky L, Ellis RJ, Lo SS, Onishi H, Swaminath A, McLaughlin M, Morgan SC, Cury F, Teh BS, Mahadevan A, Kaplan ID, Chu W, Hannan R, Staehler M, Warner A, Louie AV. Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney). International Journal of Radiation Oncology. 2022 Nov: 14(3): s177
WEBSITE
Effectiveness of Training Programs About a Palliative Care Approach: A Systematic Review of Intervention Trials for Health Care Professionals
Bainbridge D, Bishop V, Myers J, Marshall D, Stajduhar K, Seow H. Bainbridge D, Bishop V, Myers J, Marshall D, Stajduhar K, Seow H. Journal of Palliative Medicine. 2023 April; 26(4) 564-581.
WEBSITE
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415
Bai J, Pugh SL, Eldridge R, Yeager KA, Zhang Q, Lee WR, Shah AB, Dayes IS, D'Souza DP, Michalski JM, Efstathiou JA, Longo JM, Pisansky TM, Maier JM, Faria SL, Desai AB, Seaward SA, Sandler HM, Cooley ME, Bruner DW. Neighborhood Deprivation and Rurality Associated With Patient-RepNeighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415. International Journal of Radiation Oncology. 2023 May; 116(1) 39-49.
WEBSITE
Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer
Deol ES, Sanfilippo KM, Luo S, Fiala MA, Wildes T, Mian H, Schoen MW. Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer. Journal of Geriatric Oncology. 2023 June; 41(2): 396-397
WEBSITE
Pan-Canadian consensus recommendations for proton beam therapy access in Canada
Mitera G, Tsang D, McCurdy B, Goddard K, Ebacher A, Craig T, Greenland J, Kentish S, Koul R, Logie N, Morneau M, Morrison A, Pan L, Pantarotto J, Foxcroft S, Sussman J, Thompson R, Tyldesley S, Wright P, Hicks S, Brown E, Patel S; CAPCA pan-Canadian PBT Working Group. Pan-Canadian consensus recommendations for proton beam therapy access in Canada. Radiother Oncol. 2022 Nov;176:228-233.
WEBSITE
Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
Messina B, Lo Sardo F, Scalera S, Memeo L, Colarossi C, Mare M, Blandino G, Ciliberto G, Maugeri-Saccà M, Bon G. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression. Cell Death Dis. 2023 Jan 12;14(1):21.
WEBSITE
Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities.
Howell D, Pond GR, Bryant-Lukosius D, Powis M, McGowan PT, Makuwaza T, Kukreti V, Rask S, Hack S, Krzyzanowska MK. Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities. J Natl Compr Canc Netw. 2023 Mar;21(3):247-256.e8.
WEBSITE
First look at the baseline characteristics of participants in IRONMAN, the international registry for men with advanced prostate cancer.
Mucci LA, Vinson J, Gerke TA, Hyslop T, Howard L, Dreicer R, Rathkopf DE, Chi KN, Esteban E, Enting D, Bjartell A, Tagawa ST, Nanus DM, Ong M, Barata PC, Hotte SJ, Grant M, Villanti P, Kantoff PW, George DJ. First look at the baseline characteristics of participants in IRONMAN, the international registry for men with advanced prostate cancer. Journal of Clinical Oncology. 2023 Feb: 41(6) :85
WEBSITE
The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis
Barbera L, Sutradhar R, Earle CC, Howell D, Mittman N, Li Q, Thiruchelvam D, Seow H. The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis. BMJ Support Palliat Care. 2023 Oct;13(e1):e144-e149.
WEBSITE
Circulating Growth Differentiation Factor 15 as a Biomarker in Patients with Unresected Locally Advanced Non-Small Cell Lung Cancer Treated with Chemo-Radiotherapy with or without Metformin
Di Pastena F, Pond G, Ahmadi E, Tsakiridis EE, Steinberg GR, Tsakiridis T. Circulating growth differentiation factor 15 as a biomarker in patients with unresected locally advanced non-small cell lung cancer treated with chemo-radiotherapy with or without metformin. International Journal of Radiation Oncology. 2023 Oct 1 ;117(2):e14–5.
WEBSITE
Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease
Sathiyapalan A, Baloush Z, Ellis PM. Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease. Curr Oncol. 2023 Oct 29;30(11):9514-9529. doi: 10.3390/curroncol30110689. PMID: 37999109; PMCID: PMC10670056.
WEBSITE
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database
LeBlanc R, Mian H, Reece D, Masih?Khan E, Kardjadj M, Jimenez?Zepeda VH, McCurdy A, Song K, Sebag M, Louzada M, White D, Stakiw J, Kotb R, Reiman A, Aslam M, Gul E, Venner CP. Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database. British Journal of Hematology. 2022 July; 198(1) 93-102
WEBSITE
Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal.
Kotsopoulos J, Lubinski J, Gronwald J, Menkiszak J, McCuaig J, Metcalfe K, Foulkes WD, Neuhausen SL, Sun S, Karlan BY, Eisen A, Tung N, Olopade OI, Couch FJ, Huzarski T, Senter L, Bordeleau L, Singer CF, Eng C, Fruscio R, Pal T, Sun P, Narod SA. Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal. Cancer Epidemiology Biomarkers & Prevention. 2022 Jul 1;31(7):1351-1358.
WEBSITE
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups
Garcia?Horton A, Cyriac SL, Gedde?Dahl T, Floisand Y, Remberger M, Mattsson J, Michelis FV. Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups. European Journal Of Haematology. 2022 Dec;109(6):672-679.
WEBSITE
A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment
Vardy JL, Pond GR, Bell ML, Renton C, Dixon A, Dhillon HM. A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment. J Cancer Surviv. 2023 Dec;17(6):1583-1595.
WEBSITE
Patterns of care for non?metastatic castration?resistant prostate cancer: A population?based study
Malone S, Wallis CJD, Lee-Ying R, Basappa NS, Cagiannos I, Hamilton RJ, Fernandes R, Ferrario C, Gotto GT, Morgan SC, Morash C, Niazi T, Noonan KL, Rendon R, Hotte SJ, Saad F, Zardan A, Osborne B, Chan KFY, Shayegan B. Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based study. BJUI Compass. 2022 May 18;3(5):383-391.
WEBSITE
EP04.02-002 International Consensus on Actions to Improve Lung Cancer Survival: Delphi Method in the International Cancer Benchmarking Partnership
EP04.02-002 International Consensus on Actions to Improve Lung Cancer Survival: Delphi Method in the International Cancer Benchmarking Partnership. Journal of Thoracic Oncology. 2022 Sep: 17(9): s260-s261
WEBSITE
Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study
Robinson C, Chanchlani R, Gayowsky A, Brar S, Darling E, Demers C, Mondal T, Parekh R, Seow H, Batthish M. Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study. Pediatric Research. 2023 April; 93(5)1267-1275
WEBSITE
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel
Papp KA, Melosky B, Sehdev S, Hotte SJ, Beecker JR, Kirchhof MG, Turchin I, Dutz JP, Gooderham MJ, Gniadecki R, Hong C-H, Lambert J, Lynde CW, Prajapati VH, Vender RB.Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and Therapy. 2023 April; 13(4) 867-889.
WEBSITE
Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)
Berinstein NL, Roos K, Klein G, McClure R, Forward N, Shafey M, Nikonova A, MacDonald D, Villa D, Sandhu I, Aljama M, Larouche J, Mangoff K. Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM). Hematological Oncology. 2023 June; 41(2): 396-397.
WEBSITE
AGREE-S: AGREE II extension for surgical interventions: appraisal instrument
Antoniou SA, Florez ID, Markar S, Logullo P, López-Cano M, Silecchia G, Antoniou GA, Tsokani S, Mavridis D, Brouwers M; GAP Consortium. AGREE-S: AGREE II extension for surgical interventions: appraisal instrument. Surg Endosc. 2022 Aug;36(8):5547-5558.
WEBSITE
Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
Tocci P, Roman C, Sestito R, Di Castro V, Sacconi A, Molineris I, Paolini F, Carosi M, Tonon G, Blandino G, Bagnato A. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition. Cell Death Dis. 2023 Jan 5;14(1):5.
WEBSITE
LSD1 inhibition modulates transcription factor networks in myeloid malignancies
Hartung EE, Singh K, Berg T. LSD1 inhibition modulates transcription factor networks in myeloid malignancies. Front Oncol. 2023 Mar 10;13:1149754.
WEBSITE
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
Gotto GT, Yip SM, Shayegan B, O'Sullivan DE, Wallis CJD, Basappa NS, Cagiannos I, Hamilton RJ, Ferrario C, Fernandes R, Danielson B, Saad F, Hotte SJ, Brenner DR, Cheung WY, Boyne DJ, Chan K, Osborne B, Zardan A, Malone S. Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer. Journal of Clinical Oncology. 2023 Feb: 41(6):76
WEBSITE
Quality of life assessment in older patients with Newly Diagnosed Multiple Myeloma.
Mian H, Fiala M, Pond G, Wildes T. Quality of life assessment in older patients with newly-diagnosed multiple myeloma. Clinical Lymphoma Myeloma and Leukemia . 2019 Oct ;19(10):e232–3.
WEBSITE
Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)
Swaminath A, Cassim R, Millan B, Mironov O, Ahir P, Tajzler C, et al. Final results from a prospective randomized pilot trial of stereotactic body radiation therapy vs. Radiofrequency ablation for the management of small renal masses(Radster). International Journal of Radiation Oncology. 2023 Oct 1;117(2):S82.
WEBSITE
A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship care
Young K, Xiong T, Pfisterer KJ, Ng D, Jiao T, Lohani R, et al. A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship care. Commun Med . 2023 Nov 2;3(1):1–13
WEBSITE
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database
Mian H, Reece D, Masih-Khan E, McCurdy A, Kardjadj M, Jimenez-Zepeda VH, Song K, Louzada M, LeBlanc R, Sebag M, White D, Stakiw J, Reiman A, Kotb R, Aslam M, Gul E, Venner CP. Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database. Clinical Lymphoma Myeloma & Leukemia. 2022 Aug; 22(8) 608-617
WEBSITE
Emerging Biomarker-Guided Therapies in Prostate Cancer
Deluce JE, Cardenas L, Lalani A-K, Vareki SM, Fernandes R. Emerging Biomarker-Guided Therapies in Prostate Cancer. Current Oncology. 2022 Jul 18;29(7):5054-5076
WEBSITE
What do hematology residents know about caring for older adults with cancer? A national survey of Canadian hematology residents’ knowledge and interests
David V, Hsu T, Mithoowani S, Fraser G, Mian H. What do hematology residents know about caring for older adults with cancer? A national survey of Canadian hematology residents' knowledge and interests. Journal of Geriatric Oncology. 2022 Nov;13(8):1236-1240.
WEBSITE
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma
Aung KL, McWhirter E, Welch S, Wang L, Lovell S, Stayner LA, Ali S, Malpage A, Makepeace B, Ramachandran M, Jang GH, Gallinger S, Zhang T, Stockley TL, Fischer SE, Dhani N, Hedley D, Knox JJ, Siu LL, Goodwin R, Bedard PL. A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma. J Gastrointest Oncol. 2022 Dec;13(6):3216-3226.
WEBSITE
Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME; other members of the COVID-in-LTC Investigator Group. Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination. J Immunol. 2022 Nov 15;209(10):1892-1905. doi: 10.4049/jimmunol.2200369. PMID: 36426948; PMCID: PMC9666329.
WEBSITE
Future Leadership: Advanced Practice Nursing
Bryant-Lukosius D. Future Leadership: Advanced Practice Nursing. 2022: 24:1-3
WEBSITE
Evaluation of Trends in Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Across Canada During the COVID-19 Pandemic
Stecca CE, Jiang DM, Veitch Z, Hotte SJ, Alimohamed N, Wood L, Sridhar SS. Evaluation of Trends in Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Across Canada During the COVID-19 Pandemic. Clinical Genitourinary Cacner. 2023 April; 21(2) 273-277.
WEBSITE
Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies
Sayeda S, Naqvi A, Begum H, Juergens RA, Finley C, Coschi CH, Cutz J-C, Bonert M. Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies. Cureus. 2023 April;15(4): 3705
WEBSITE
Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study
Taylor C, McGale P, Probert J, Broggio J, Charman J, Darby SC, Kerr AJ, Whelan T, Cutter DJ, Mannu G, Dodwell D. Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study. The BMJ. 2023 June; 381: 074684
WEBSITE
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance
Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G. Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance. Oncogene. 2023 Jan; 42(4); 293-307.
WEBSITE
18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer
Mesci A, Ahmadi E, Ali A, Gouran-Savadkoohi M, Evelyn Tsakiridis E, Biziotis OD, Chow T, Kapoor A, Sur M, Steinberg GR, Liu S, Zukotynski K, Tsakiridis T. 18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer. Clin Transl Radiat Oncol. 2023 Jan 18;39:100583
WEBSITE
Antiviral therapy defiant mixed viral retinitis post hematopoietic allogeneic stem cell transplant
Gabarin N, Dadak R, Roy M, Kaplan AJ, Haider S, Khalaf D. Antiviral therapy defiant mixed viral retinitis post hematopoietic allogeneic stem cell transplant. Clin Case Rep. 2023 Mar 15;11(3):e7095.
WEBSITE
Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.
Ma LX, Loree JM, Jonker DJ, Kennecke HF, Berry SR, Couture F, Ahmad CE, Goffin JR, Kavan P, Harb M, Colwell B, Samimi S, Samson B, Abbas T, Aucoin N, Aubin F, Koski SL, Tu D, O'Callaghan CJ, Chen EX. Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial. Journal of Clinical Oncology. 2023 Feb:41(6):183
WEBSITE
Performance of externally validated machine learning models based on histopathology images for the diagnosis, classification, prognosis, or treatment outcome prediction in female breast cancer: A systematic review
Gonzalez R, Nejat P, Saha A, Campbell CJV, Norgan AP, Lokker C. Performance of externally validated machine learning models based on histopathology images for the diagnosis, classification, prognosis, or treatment outcome prediction in female breast cancer: A systematic review. Journal of Pathology Informatics . 2024 Dec 1 ;15:100348
WEBSITE
Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)
Schep DG, Vansantvoort J, Dayes I, Lukka H, Quan K, Kapoor A, et al. Evaluation of volumetric response assessment from stereotactic ablative radiotherapy (Sabr) for renal cell carcinoma(Rcc). International Journal of Radiation Oncology. 2023 Dec 12
WEBSITE
Presentation and outcomes of KRAS G12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence
Esfahanian N, Chan SWS, Zhan LJ, Brown MC, Khan K, Lee J, et al. Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (De novo) versus at recurrence. Cancer Treatment and Research Communications 2023 Jan ;37:100774.
WEBSITE
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient?reported outcome measures (PROMs)
Balitsky AK, D'Souza A, Levine MN. Important questions for the malignant hematologist to consider when designing or evaluating a study with patient?reported outcome measures (PROMs). European Journal of Haematology. 2022 July; 109(1) 1-3
WEBSITE
Recurrence after stopping anticoagulants in women with combined oral contraceptive?associated venous thromboembolism: A systematic review and meta?analysis
Abdulrehman J, Elbaz C, Aziz D, Parpia S, Fazelzad R, Eischer L, Rodger MA, Cannegieter SC, Cate?Hoek AT, Nagler M, Schulman S, Rezende SM, Olié V, Palareti G, Marcucci M, Douketis J, Poli D, Zabczyk M, de Sousa DA, Miranda B, Cushman M, Tosetto A, Le Gal G, Kearon C, Skeith L. Recurrence after stopping anticoagulants in women with combined oral contraceptive?associated venous thromboembolism: A systematic review and meta?analysis. British Journal of Haematology. 2022 Oct;199(1):130-142
WEBSITE
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall E, van As N, Lartigau E, Patton S, Thompson A, Winkler M, Wells P, Lymberiou T, Saunders D, Vilarino-Varela M, Vavassis P, Tsakiridis T, Carlson R, Rodrigues G, Tanguay J, Iqbal S, Winkler M, Morgan S, Mihai A, Li A, Din O, Panades M, Wade R, Rimmer Y, Panades M, Oommen N. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomized, phase 3, non-inferiority trial. The Lancet. 2022 Oct. 23(10): 1308-1320.
WEBSITE
Patient and Healthcare Provider Perspectives on the Implementation of a Web-Based Clinical Communication System for Cancer: A Qualitative Study
Petrovic B, O'Brien MA, Liddy C, Afkham A, McGee SF, Morgan SC, Segal R, Bender JL, Sussman J, Urquhart R, Fitch M, Schneider ND, Grunfeld E. Patient and Healthcare Provider Perspectives on the Implementation of a Web-Based Clinical Communication System for Cancer: A Qualitative Study. Curr Oncol. 2022 Nov 3;29(11):8401-8414.
WEBSITE
Choosing which in-hospital laboratory tests to target for intervention: a scoping review
Podolsky E, Hudek N, McCudden C, Presseau J, Yanikomeroglu S, Brouwers M, Brehaut JC. Choosing which in-hospital laboratory tests to target for intervention: a scoping review. Clin Chem Lab Med. 2022 Nov 22;61(3):388-401. doi: 10.1515/cclm-2022-0910. PMID: 36410390; PMCID: PMC9876731.
WEBSITE
Dosing, efficacy and safety of lenvatinb in the real?world treatment of hepatocellular carcinoma: Results from a Canadian database
Amaro CP, Allen MJ, Knox JJ, Tsang ES, Lim HJ, Lee?Ying RM, Chan KW, Qian J, Meyers BM, Thawer A, Al?Saadi SMS, Hsu T, Ramjeesingh R, Karachiwala H, Abedin T, Tam VC. Dosing, efficacy and safety of lenvatinb in the real?world treatment of hepatocellular carcinoma: Results from a Canadian database. Liver Cancer International. 2023 Jun:3(3): 119-127
WEBSITE
Association of circulating markers with cognitive decline after radiation therapy for brain metastasis.
Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary J-P, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 2023 June; 25(6) 1123-1131.
WEBSITE
Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023]
Ernst MS, Navani V, Wells JC, Donskov F, Basappa N, Labaki C, Pal SK, Meza L, Wood LA, Ernst DS, Szabados B, McKay RR, Parnis F, Suarez C, Yuasa T, Lalani A-K, Alva A, Bjarnason GA, Choueiri TK, Heng DYC. Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023]. European Urology. 2023 June"83(6) 166-167
WEBSITE
GDF15 promotes weight loss by enhancing energy expenditure in muscle
Wang D, Townsend LK, DesOrmeaux GJ, Frangos SM, Batchuluun B, Dumont L, Kuhre RE, Ahmadi E, Hu S, Rebalka IA, Gautam J, Jabile MJT, Pileggi CA, Rehal S, Desjardins EM, Tsakiridis EE, Lally JSV, Juracic ES, Tupling AR, Gerstein HC, Paré G, Tsakiridis T, Harper M-E, Hawke TJ, Speakman JR, Blondin DP, Holloway GP, Jørgensen SB, Steinberg GR. Nature. GDF15 promotes weight loss by enhancing energy expenditure in muscle2023 July; 619(7968): 143-150.
WEBSITE
Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma.
Sekely A, Bernstein LJ, Campbell KL, Mason WP, Laperriere N, Kalidindi N, Or R, Ramos R, Climans SA, Pond GR, Ann Millar B, Shultz D, Tsang DS, Zadeh G, Edelstein K. Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma. Neurooncol Pract. 2022 Sep 13;10(1):89-96.
WEBSITE
Definitive High-Dose Radiotherapy for Primary Vulvar Cancer: The DRIVE Multicenter Cohort Study
Rishi A, Albuquerque KV, Donovan E, Jhingran A, Beriwal S, Glaser SM, Fernandez DC, Ahmed KA, Montejo ME. Definitive High-Dose Radiotherapy for Primary Vulvar Cancer: The DRIVE Multicenter Cohort Study. International Journal of Radiation Oncology. Nov 2023. 114(3). s136-s137.
WEBSITE
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease
Saleh AH, Rothe M, Barber DL, McKillop WM, Fraser G, Morel CF, Schambach A, Auray-Blais C, West ML, Khan A, Fowler DH, Rupar CA, Foley R, Medin JA, Keating A. Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. Mol Ther Methods Clin Dev. 2023 Jan 18;28:262-271.
WEBSITE
Development and Validation of an Indicator for Oncofertility Care in Ontario, Canada, for Adolescents and Young Adults with Cancer
Rae CS, Barr RD, Seow H, Costa A. Development and Validation of an Indicator for Oncofertility Care in Ontario, Canada, for Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2023 May 5.
WEBSITE
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):370-377.
WEBSITE
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Anagnostou V, Ho C, Nicholas G, Juergens RA, Sacher A, Fung AS, et al. Ctdna response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nat Med. 2023 Oct ;29(10):2559–69.
WEBSITE
Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history
Bonert M, Berzins A, Begum H, Schittenhelm J, Lu JQ, Juergens RA, et al. Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history. PLOS ONE . 2023 Nov ;18(11):e0294154.
WEBSITE
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient?derived endothelial colony?forming cells
Bowman M, Casey L, Selvam SN, Lima PDA, Rawley O, Hinds M, Tuttle A, Grabell J, Iorio A, Walker I, Lillicrap D, James P. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient?derived endothelial colony?forming cells. 2022 July. 20(7) 1599-1609
WEBSITE
Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma
Griffiths CD, Zhang B, Tywonek K, Meyers BM, Serrano PE. Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA Network Open. 2022 Jul 1;5(7):e2222721.
WEBSITE
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Tatari N, Khan S, Livingstone J, Zhai K, Mckenna D, Ignatchenko V, Chokshi C, Gwynne WD, Singh M, Revill S, Mikolajewicz N, Zhu C, Chan J, Hawkins C, Lu J-Q, Provias JP, Ask K, Morrissy S, Brown S, Weiss T, Weller M, Han H, Greenspoon JN, Moffat J, Venugopal C, Boutros PC, Singh SK, Kislinger T. The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers. Acta Neuropathologica. 2022 Dec;144(6):1127-1142.
WEBSITE
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi?institutional report from the Canadian Myeloma Research Group (CMRG) Database
McCurdy A, Louzada M, Venner CP, Visram A, Masih-Khan E, Kardjadj M, Jimenez-Zepeda VH, LeBlanc R, Sebag M, Song K, White D, Mian H, Stakiw J, Reiman A, Aslam M, Kotb R, Gul E, Reece D. Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database. EJHaem. 2022 Aug 31;3(4):1252-1261.
WEBSITE
BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
Chu Q, Leighl NB, Surmont V, van Herpen C, Sibille A, Markman B, Clarke S, Juergens RA, Rivera MA, Andelkovic V, Rudin CM, Snow S, Kim DW, Sanatani M, Lin H, Sanghavi K, Tannenbaum-Dvir S, Basciano P, Lathers D, Urbanska K, Kollia G, He C, DiPiero A, Liu Y, Ready N. BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study. JTO Clin Res Rep. 2022 Aug 27;3(11):100400. doi: 10.1016/j.jtocrr.2022.100400. PMID: 36275912; PMCID: PMC9579497.
WEBSITE
Rurality index score and pediatric neuro-oncological outcome in Ontario.
Kameda-Smith MM, Pond GR, Seow H. Rurality index score and pediatric neuro-oncological outcome in Ontario. Journal of Neurosurgery Pediatrics. 2023 April; 31(4) 275-281.
WEBSITE
Impact of bortezomib?based versus lenalidomide maintenance therapy on outcomes of patients with high?risk multiple myeloma
Bumma N, Dhakal B, Fraser R, Estrada?Merly N, Anderson K, Freytes CO, Hildebrandt GC, Holmberg L, Krem MM, Lee C, Lekakis L, Lazarus HM, Mian H, Murthy HS, Nathan S, Nishihori T, Parrondo R, Patel SS, Solh M, Strouse C, Vesole DH, Kumar S, Qazilbash MH, Shah N, D’Souza A, Sidana S.Impact of bortezomib?based versus lenalidomide maintenance therapy on outcomes of patients with high?risk multiple myeloma. Cancer. 2023 July;129(14):2179
WEBSITE
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
Melosky BL, Leighl NB, Dawe D, Blais N, Wheatley-Price PF, Chu QS-C, Juergens RA, Ellis PM, Sun A, Schellenberg D, Ionescu DN, Cheema PK. Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer. Current Oncology.
WEBSITE
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2 or ATM Alterations Identified by Testing Circulating Tumor DNA
Matsubara N, de Bono J, Olmos D, Procopio G, Kawakami S, Ürün Y, van Alphen R, Flechon A, Carducci MA, Choi YD, Hotte SJ, Korbenfeld E, Kramer G, Agarwal N, Chi KN, Dearden S, Gresty C, Kang J, Poehlein C, Harrington EA, Hussain M. Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA. Clin Cancer Res. 2023 Jan 4;29(1):92-99.
WEBSITE
Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysis
Mian O, Puts M, McCurdy A, Wildes TM, Fiala MA, Kang M, Salib M, Alibhai S, Mian H. Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysis. Front Oncol. 2023 Jan 27;12:974038.
WEBSITE
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Lancet. 2023 Jan 28;401(10373):269-280.
WEBSITE
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023 Jun 3;401(10391):1853-1865.
WEBSITE
Accuracy of physicians’ intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis
van Maanen R, Martens ESL, Takada T, Roy PM, de Wit K, Parpia S, Kraaijpoel N, Huisman MV, Wells PS, Le Gal G, Righini M, Freund Y, Galipienzo J, van Es N, Blom JW, Moons KGM, Rutten FH, van Smeden M, Klok FA, Geersing GJ, Luijken K. Accuracy of physicians' intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis. J Thromb Haemost. 2023 Oct;21(10):2873-2883.
WEBSITE
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Khurshid H, Ismaila N, Bian J, Dabney R, Das M, Ellis P, Feldman J, Hann C, Kulkarni S, Laskin J, Manochakian R, Mishra DR, Preeshagul I, Reddy P, Saxena A, Weinberg F, Kalemkerian GP. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline. J Clin Oncol. 2023 Dec 10;41(35):5448-5472.
WEBSITE
Seeing the random forest through the decision trees. Supporting learning health systems from histopathology with machine learning models: Challenges and opportunities
Gonzalez R, Saha A, Campbell CJV, Nejat P, Lokker C, Norgan AP. Seeing the random forest through the decision trees. Supporting learning health systems from histopathology with machine learning models: Challenges and opportunities. Journal of Pathology Informatics. 2024 Dec ];15:100347
WEBSITE
Metformin-induced reductions in tumor growth involves modulation of the gut microbiome
Broadfield LA, Saigal A, Szamosi JC, Hammill JA, Bezverbnaya K, Wang D, Gautam J, Tsakiridis EE, Di Pastena F, McNicol J, Wu J, Syed S, Lally JSV, Raphenya AR, Blouin M-J, Pollak M, Sacconi A, Blandino G, McArthur AG, Schertzer JD, Surette MG, Collins SM, Bramson JL, Muti P, Tsakiridis T, Steinberg GR. Metformin-induced reductions in tumor growth involves modulation of the gut microbiome. Molecular Metabolism. 2022 July; 61
WEBSITE
Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma
D'Souza A, Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD, Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee CH, Mian H, Nathan S, Savani BN, Kumar SK, Qazilbash MH, Shah N. Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma. Blood Advances. 2022 Jul 12;6(13):3991-3995
WEBSITE
Perioperative management of myeloproliferative neoplasms: A pan?Canadian physician survey and international expert opinion
Szuber N, Toliopoulos P, Busque L, Cerquozzi S, Foltz L, Gupta V, Tefferi A, Vannucchi AM, Hillis C, Leber B, Maze D, Prchal J, Olney HJ, Sirhan S. Perioperative management of myeloproliferative neoplasms: A pan?Canadian physician survey and international expert opinion. American Journal of Hematology. 2022 Dec;97(12):E466-E469.
WEBSITE
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
Scott SA, Llaurado Fernandez M, Kim H, Elit L, Nourmoussavi M, Glaze S, Roberts L, Offman SL, Rahimi K, Lytwyn A, Sur M, Gilks CB, Matheson K, Köbel M, Dawson A, Tinker AV, Kwon JS, Hoskins P, Santos JL, Cheung A, Provencher D, Carey MS; Canadian LGSC Community of Practice (GOC-CoP). Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes. Gynecol Oncol. 2020 Apr;157(1):36-45.
WEBSITE
Physician and Surgeon Communication Assessed via the Pathology Requisition in a Regional Laboratory Over Ten Years
Bonert M, Zafar U, Williams P, El-Shinnawy I, Juergens RA, Naqvi A, Cutz JC, Finley C, Major P, Kapoor A. Physician and Surgeon Communication Assessed via the Pathology Requisition in a Regional Laboratory Over Ten Years. Cureus. 2022 Aug 5;14(8):e27714. doi: 10.7759/cureus.27714. PMID: 36081978; PMCID: PMC9441211.
WEBSITE
BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy
Sur R, Pond G, Falkson C, Pan M, Wright J, Bezjak A, Dagnault A, Yu E, Almahmudi M, Puksa S, Gopaul D, Tsakiridis T, Swaminath A, Ellis P, Whelan T. BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy. International Journey of Radiation Oncology. 2023 July; 116(3) 601-610.
WEBSITE
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
Mian H, Ringash J, Meyer R, Hay AE, Shepherd L, Djurfeldt M, Winter JN, Sussman J, Pater J, Chen BE, Prica A. Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6. Supportive Care in Cancer. 2023 May;31(5):256
WEBSITE
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey
Al-Ezzi EM, Zahralliyali A, Hansen AR, Hamilton RJ, Crump M, Kuruvilla J, Wood L, Nappi L, Kollmannsberger CK, North SA, Winquist E, Soulières D, Hotte SJ, Jiang DM. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey. Current Oncology. 2023 June; 30(7): 6166-6176
WEBSITE
Information Provision, Decision Self-efficacy, and Decisional Conflict in Adopting Health Behaviors Among Patients Treated for Colorectal Cancer
Lee MK, Bryant-Lukosius D. Information Provision, Decision Self-efficacy, and Decisional Conflict in Adopting Health Behaviors Among Patients Treated for Colorectal Cancer: A Cross-sectional Study. Cancer Nurs. 2023 Jan-Feb 01;46(1):45-56. doi: 10.1097/NCC.0000000000001040. Epub 2021 Nov 24. PMID: 34817417.
WEBSITE
Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer
Zhao H, Pond G, Simos D, Wang Z, Robertson S, Singh G, Vandermeer L, Clemons M, Addison CL. Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer. Cancers (Basel). 2023 Jan 17;15(3):571.
WEBSITE
Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills
Howell D, McGowan P, Bryant-Lukosius D, Kirkby R, Powis M, Sherifali D, Kukreti V, Rask S, Krzyzanowska MK. Impact of a Training Program on Oncology Nurses' Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills. Cancers (Basel). 2023 Mar 16;15(6):1811
WEBSITE
Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota
D’Anca M, Buccellato FR, Tartaglia GM, Del Fabbro M, Muti P, Scarpini E, Galimberti D, Ghezzi L. Why Is Multiple Sclerosis More Frequent in Womn? Role of the Immune System and of Oral and Gut Microbiota. Applied Sciences. 2023; 13(10):588
WEBSITE
HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden-induced T-cell Exhaustion.
Nguyen A, Brown D, Krishnan R, Bastin D, Deng L, Chen L, Salem O, Walsh SR, Bramson JL, Wan Y. HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden-induced T-cell Exhaustion. Clin Cancer Res. 2023 Oct 13;29(20):4289-4305.
WEBSITE
CN57 Patients, informal caregivers and healthcare professionals experience in adoptive cell therapies: An experience-based co-design study (EBCD-ACT)
Canova N, Graber N, Corbière T, Bosisio F, Kaufmann A, Bryant-Lukosius D, Eicher M, Colomer-Lahiguera S. CN57 Patients, informal caregivers and healthcare professionals experience in adoptive cell therapies: An experience-based co-design study (EBCD-ACT). Annals of Oncology. Oct 2023, 34: s1242
WEBSITE
Pembrolizumab-induced immune-related sclerosing cholangitis
Liang I, Chu G, Zielinski R. Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy. Case Rep Oncol. 2023 Mar 31;16(1):182-187.
WEBSITE
Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis
Parpia S, Morris TP, Phillips MR, Wykoff CC, Steel DH, Thabane L, Bhandari M, Chaudhary V. Sensitivity analysis in clinical trials: three criteria for a valid sensitivity analysis. Eye. 2-22 Nov; 36(11) 2073-2074
WEBSITE
Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study
Piedimonte S, Pond GR, Plante M, Nelson G, Kwon J, Altman A, Feigenberg T, Elit L, Lau S, Sabourin J, Willows K, Aubrey C, Jang J-H, Teo-Fortin L-A, Cockburn N, Saunders N-B, Shamiya S, Helpman L, Vicus D, Collaborative OBOTCCCC. Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study. Gynecologic Oncology. 2022 Aug;166(2):230-235.
WEBSITE
Why do we not reverse the path? Stress can cause depression, reduction of brain-derived neurotrophic factor and increased inflammation
Claro AE, Palanza C, Mazza M, Rizzi A, Tartaglione L, Marano G, Muti-Schuenemann G, Rigoni M, Muti P, Pontecorvi A, Janiri L, Sani G, Pitocco D. Why do we not reverse the path? Stress can cause depression, reduction of brain-derived neurotrophic factor and increased inflammation. World Journal of Psychiatry. 2022 Sep 19; 12(9): 1264–1267.
WEBSITE
Quality of End-of-Life Care in Gastrointestinal Cancers: A 13-Year Population-Based Retrospective Analysis in Ontario, Canada
Lees CS, Seow H, Chan KK, Gayowsky A, Sinnarajah A. Quality of End-of-Life Care in Gastrointestinal Cancers: A 13-Year Population-Based Retrospective Analysis in Ontario, Canada. Curr Oncol. 2022 Nov 24;29(12):9163-9171.
WEBSITE
Barriers to Access: Global Variability in Implementing Treatment Advances in Lung Cancer.
Febbraro M, Gheware A, Kennedy T, Jain D, de Moraes FY, Juergens R. Barriers to Access: Global Variability in Implementing Treatment Advances in Lung Cancer. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-7. doi: 10.1200/EDBK_351021. PMID: 35427189.
WEBSITE
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma
Ernst MS, Navani V, Wells JC, Donskov F, Basappa N, Labaki C, Pal SK, Meza L, Wood LA, Ernst DS, Szabados B, McKay RR, Parnis F, Suarez C, Yuasa T, Lalani A-K, Alva A, Bjarnason GA, Choueiri TK, Heng DYC. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. European Urology. 2023 July; 84(1) 109-116.
WEBSITE
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab.
Zhou S, Cirne F, Chow J, Zereshkian A, Bordeleau L, Dhesy-Thind S, Ellis PM, Mukherjee SD, Aghel N, Leong DP. Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab. The Oncologist. 2023 May.
WEBSITE
Education modalities for serious illness communication training: A scoping review on the impact on clinician behavior and patient outcomes.
Lavecchia M, Myers J, Bainbridge D, Incardona N, Levine O, Steinberg L, Schep D, Vautour J, Kumar SJ, Seow H. Education modalities for serious illness communication training: A scoping review on the impact on clinician behavior and patient outcomes. Palliative Medicine. 2023 July.
WEBSITE
Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Systematic Review
Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Systematic Review. J Thorac Oncol. 2023 Mar;18(3):299-312. doi: 10.1016/j.jtho.2022.10.016. Epub 2022 Nov 4. PMID: 36343922.
WEBSITE
Use of population-based electronic databases for the identification of patients with synchronous colorectal cancer and liver metastases potentially eligible for a surgical trial
Serrano PE, Griffiths CD, Fabbro M, Jibrael S, Levine M, Bhandari M, Parpia S, Simunovic M. Use of population-based electronic databases for the identification of patients with synchronous colorectal cancer and liver metastases potentially eligible for a surgical trial. Can J Surg. 2023 Feb 2;66(1):E52-E58
WEBSITE
Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists
Petrovic B, Bender JL, Liddy C, Afkham A, McGee SF, Morgan SC, Segal R, O’Brien MA, Julian JA, Sussman J, Urquhart R, Fitch M, Schneider ND, Grunfeld E. Implementation of a Web-Based Communication System for Primary Care Providers and Cancer Specialists. Current Oncology. 2023; 30(3):3537-3548.
WEBSITE
Activated KRAS, polyamines, iASPP and TME: a multiple liaison in pancreatic cancer
Blandino G. Activated KRAS, polyamines, iASPP and TME: a multiple liaison in pancreatic cancer. Cell Death Differ. 2023 Jun;30(6):1615-1617
WEBSITE
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non?small cell lung cancer (NSCLC) through inhibition of HIF?1?
Biziotis OD, Tsakiridis EE, Ali A, Ahmadi E, Wu J, Wang S, Mekhaeil B, Singh K, Menjolian G, Farrell T, Abdulkarim B, Sur RK, Mesci A, Ellis P, Berg T, Bramson JL, Muti P, Steinberg GR, Tsakiridis T. Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1?. Mol Oncol. 2023 Nov;17(11):2235-2256.
WEBSITE
Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients With Metastatic Urothelial Carcinoma.
Petrylak DP, Eigl BJ, George S, Heath EI, Hotte SJ, Chism DD, Nabell LM, Picus J, Cheng SY, Appleman LJ, Sonpavde GP, Morgans AK, Pourhosseini P, Wu R, Standley L, Croitoru R, Yu EY. Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients With Metastatic Urothelial Carcinoma. Clin Cancer Res. 2023 Oct 20.
WEBSITE
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia
Alshamleh I, Kurrle N, Makowka P, Bhayadia R, Kumar R, Süsser S, Seibert M, Ludig D, Wolf S, Koschade SE, Stoschek K, Kreitz J, Fuhrmann DC, Toenges R, Notaro M, Comoglio F, Schuringa JJ, Berg T, Brüne B, Krause DS, Klusmann J-H, Oellerich T, Schnütgen F, Schwalbe H, Serve H. PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia. Leukemia. 2023 Nov 37(12):1-16
WEBSITE
Transfusion thresholds in myelodysplastic syndrome—Helping patients live better
Balitsky A, Arnold D. Transfusion thresholds in myelodysplastic syndrome—Helping patients live better. Transfusion. 2022 July; 62(7) 1313-1314
WEBSITE
The impact of the Caremongering social media movement: A convergent parallel mixed?methods study
Bishop V, Bainbridge D, Kumar S, Williams A, Law M, Pesut B, Chochinov H, Seow H. The impact of the Caremongering social media movement: A convergent parallel mixed?methods study. Health and Social Care in the Community. 2022 Nov;30(6):e5167-e5175.
WEBSITE
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
Singh N, Temin S, Baker S, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. Journal of Clinical Oncology. 2023 Feb 10;41(5):e10-e20.
WEBSITE
Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials
Kharofa JR, Yothers G, Kachnic LA, Ajani J, Meyer JE, Augspurger ME, Okawara GS, Garg MK, Schefter TE, Swanson TA, Doncals DE, Kim H, Zaki BI, Narayan S, Lee RJ, Mamon HJ, Schwartz MA, Moughan J, Crane CH. Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529. Am J Clin Oncol. 2022 Dec 1;45(12):534-536.
WEBSITE
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Siva S, Ali M, Correa RJM, Muacevic A, Ponsky L, Ellis RJ, Lo SS, Onishi H, Swaminath A, McLaughlin M, Morgan SC, Cury FL, Teh BS, Mahadevan A, Kaplan ID, Chu W, Grubb W, Hannan R, Staehler M, Warner A, Louie AV. 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney). Lancet Oncol. 2022 Dec;23(12):1508-1516. doi: 10.1016/S1470-2045(22)00656-8. Epub 2022 Nov 16. PMID: 36400098.
WEBSITE
Management of Patients with Cardiovascular Implantable Electronic Devices Undergoing Radiation Therapy: A National Survey of Canadian Multidisciplinary Radiation Oncology Professionals
Safavi AH, Louie AV, Elzibak AH, Warner A, Donovan EK, Detsky JS. Management of Patients with Cardiovascular Implantable Electronic Devices Undergoing Radiation Therapy: A National Survey of Canadian Multidisciplinary Radiation Oncology Professionals. Advances in Radiation Oncology. 2023 July; 8(4) 101-184.
WEBSITE
Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada
Wong WWL, Lee L, Walker S, Lee C, Patel T, Hillier LM, Costa AP, Sinha SK. Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada. BMJ Open. 2023 April;13(4) : 648
WEBSITE
Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification
Hird AE, Chavarriaga J, Lalani A-KA, Wallis CJD. Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification. European Urology. 2023 July; 2838(23)
WEBSITE
The European Society of Cardiology Cardio-Oncology Guidelines Evidence Base, Actionability, and Relevance to Clinical Practice
Leong DP, Mukherjee SD. The European Society of Cardiology Cardio-Oncology Guidelines. J Am Coll Cardiol CardioOnc. 2023 Feb;5 (1);137–140.
WEBSITE
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study
Aubrey C, Pond GR, Helpman L, Vicus D, Elit L, Plante M, Lau S, Kwon JS, Altman AD, Willows K, Feigenberg T, Sabourin J, Samouelian V, Bernard L, Cockburn N, Saunders NB, Piedimonte S, Teo-Fortin LA, Kim SR, Sadeq N, Jang JH, Shamiya S, Nelson G. Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study. Curr Oncol. 2023 Feb 6;30(2):1977-1985.
WEBSITE
Regularly scheduled physical examinations and the detection of breast cancer recurrences
Beltran-Bless AA, Alshamsan B, Alzahrani MJ, Hilton J, Baines KA, Samuel V, Pond GR, Vandermeer L, Clemons M, Larocque G. Regularly scheduled physical examinations and the detection of breast cancer recurrences. Breast. 2023 Jun;69:274-280.
WEBSITE
A Two-Center Experience: The Impact of COVID-19 on Two Brachytherapy Programs in Ontario – Virtual Care, Service Suspension and Radiation Therapy Workflow
Chan K, Timotin E, Chung P, Han K, Milosevic M, Schnarr K, Sur R, Bosche J, Harnett N. A two-center experience: The impact of COVID-19 on two brachytherapy programs in Ontario - virtual care, service suspension and radiation therapy workflow. J Med Imaging Radiat Sci. 2023 Sep;54(3):436-445. doi: 10.1016/j.jmir.2023.05.043. Epub 2023 May 29. PMID: 37357051; PMCID: PMC10289124.
WEBSITE
Current and Future Treatment Options in the Management of Stage III NSCLC
Li Y, Juergens RA, Finley C, Swaminath A. Current and Future Treatment Options in the Management of Stage III NSCLC. J Thorac Oncol. 2023 Nov;18(11):1478-1491
WEBSITE
Transitional care from hospital to home: how to target the right population?
Michalski-Monnerat C, Jacquot-Pegeot ML, Rochat S, Schmid MC, Maillat Roth S, Chevrey N, Toledano Y, Jeannot JG, Donzé J, Bryant-Lukosius D, Mabire C. Soins de transition entre l’hôpital et le domicile: pour quels patient-es ? [Transitional care from hospital to home: how to target the right population?]. Rev Med Suisse. 2023 Oct 25;19(847):2021-2025..
WEBSITE
Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy: Trial-Level Meta-Analysis and Individual-Level Analysis of NRG/RTOG 0617 and PROCLAIM
Hu C, Miccio JA, Dignam JJ, Paulus R, Liu C, Skinner HD, et al. Progression-free survival as a surrogate endpoint of overall survival in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy: trial-level meta-analysis and individual-level analysis of nrg/rtog 0617 and proclaim. International Journal of Radiation Oncology . 2023 Oct 1 ;117(2):S128.
WEBSITE
Effectiveness of registered nurses on patient outcomes in primary care: a systematic review
Lukewich J, Martin-Misener R, Norful AA, Poitras M-E, Bryant-Lukosius D, Asghari S, Marshall EG, Mathews M, Swab M, Ryan D, Tranmer J. Effectiveness of registered nurses on patient outcomes in primary care: a systematic review. BMC Services Research. 2022 Dec; 22(1) 740
WEBSITE
Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer
Xu K, Bayani J, Mallon E, Pond GR, Piper T, Hasenburg A, Markopoulos CJ, Dirix L, Seynaeve CM, van de Velde CJH, Rea DW, Bartlett JMS. Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer. Journal of Molecular Diagnostics. 2022 Jul;24(7):775-783.
WEBSITE
Disparities in the survival of endometrial cancer patients in a public healthcare system: A population-based cohort study
Helpman L, Pond GR, Elit L, Anderson LN, Kong I, Schnarr K, Seow H. Disparities in the survival of endometrial cancer patients in a public healthcare system: A population-based cohort study. Gynecologic Oncology. 2022 Dec;167(3):532-539.
WEBSITE
Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9–14 years in rural communities of Northwest Cameroon: a qualitative study
Elit L, Ngalla C, Afugchwi GM, Tum E, Domgue JF, Nouvet E. Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9-14 years in rural communities of Northwest Cameroon: a qualitative study. BMJ Open. 2022 Nov 15;12(11):e068212.
WEBSITE
Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis
Sathiyapalan A, Febbraro M, Pond GR, Ellis PM. Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis. Curr Oncol. 2022 Nov 22;29(12):9046-9065.
WEBSITE
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium
Côté J, Kotb R, Bergstrom DJ, LeBlanc R, Mian HS, Othman I, Louzada ML. First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium. Clinical Lymphoma Myeloma & Leukemia. 2023 May; 23(5) 340-354.
WEBSITE
Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study
Selby R, Kaus L, Sealey F, Koo M, Parpia S, Chan B, Seung SJ, Bradley C, Strauss R, Mittmann N. Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicenter, prospective study. PLOS ONE. 2023;18(4)" 284
WEBSITE
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
Barbour AB, Kirste S, Grosu A-L, Siva S, Louie AV, Onishi H, Swaminath A, Teh BS, Psutka SP, Weg ES, Chen JJ, Zeng J, Gore JL, Hall E, Liao JJ, Correa RJM, Lo SS. The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma. Cancers. 2023 July; 15(14): 3672
WEBSITE
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma
Parmar A, Ghosh S, Sahgal A, Lalani AA, Hansen AR, Reaume MN, Wood L, Basappa NS, Heng DYC, Graham J, Kollmannsberger C, Soulières D, Breau RH, Tanguay S, Kapoor A, Pouliot F, Bjarnason GA. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma. Cancer Rep (Hoboken). 2023 Mar;6(3):e1763. doi: 10.1002/cnr2.1763. Epub 2022 Dec 14. PMID: 36517084; PMCID: PMC10026314.
WEBSITE
In Response to Morgan et al. and Li et al.
Goldberg M, McGale P, Whelan TJ. In Response to Morgan et al. and Li et al. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):1012-1013
WEBSITE
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA. Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171). J Thorac Oncol. 2023 Jun;18(6):813-819.
WEBSITE
Corrigendum to methodological approaches for developing, reporting, and assessing evidence-based clinical practice guidelines: a systematic survey [Journal of Clinical Epidemiology 146 (2022) 77-85]
Yao X, Xia J, Jin Y, Shen Q, Wang Q, Zhu Y, McNair S, Sussman J, Wang Z, Florez ID, Zeng XT, Brouwers M. Corrigendum to methodological approaches for developing, reporting, and assessing evidence-based clinical practice guidelines: a systematic survey [Journal of Clinical Epidemiology 146 (2022) 77-85]. J Clin Epidemiol. 2023 Jul;159:354-355. doi: 10.1016/j.jclinepi.2023.04.003. Epub 2023 Jun 9. Erratum for: J Clin Epidemiol. 2022 Jun;146:77-85. PMID: 37302874.
WEBSITE
Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK
Gonzalez JM, Ganguli A, Morgans AK, Tombal BF, Hotte SJ, Suzuki H, Bhadauria H, Oh M, Scales CD Jr, Wallace MJ, Yang JC, George DJ. Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK. Patient. 2023 Nov;16(6):607-623.
WEBSITE
Radiotherapy for Liver Cancer: An International Multi-Centre Pooled Analysis of 925 Cases
Chow R, Biswas T, Liu H, Pryor DI, Chu W, Swaminath A, Chung HT, Schellenberg D, Grindrod N, Lee YY, Gaede S, Sachdeva R, Lock MI. Radiotherapy for Liver Cancer: An International Multi-Centre Pooled Analysis of 925 Cases. International Journal of radiation Oncology. Oct 2023: 1172(2)
WEBSITE
Enhanced recovery after surgery protocols following emergency intra-abdominal surgery: a systematic review and meta-analysis
McKechnie T, Tessier L, Archer V, Park L, Cohen D, Levac B, Parpia S, Bhandari M, Dionne J, Eskicioglu C. Enhanced recovery after surgery protocols following emergency intra-abdominal surgery: a systematic review and meta-analysis. Eur J Trauma Emerg Surg. 2023 Nov 20. doi: 10.1007/s00068-023-02387-6. Epub ahead of print. PMID: 37985500.
WEBSITE
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy
Graham J, Wells JC, Dudani S, Gan CL, Donskov F, Lee J-L, Kollmannsberger CK, Meza L, Beuselinck B, Hansen A, North SA, Bjarnason GA, Sayegh N, Kanesvaran R, Wood LA, Hotte SJ, McKay RR, Choueiri TK, Heng DYC. Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer. 2022 Aug; 171: 124-132
WEBSITE
Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma
Cardenas LM, Deluce JE, Khan S, Gulam O, Vareki SM, Fernandes R, Lalani A-KA. Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma. Current Oncology. 2022 Jul 30;29(8):5426-5441.
WEBSITE
Trends in quality indicators of end-of-life care for women with gynecologic malignancies in Ontario, Canada
Mah SJ, Seow H, Schnarr K, Reade CJ, Gayowsky A, Chan KKW, Sinnarajah A. Trends in quality indicators of end-of-life care for women with gynecologic malignancies in Ontario, Canada. Gynecologic Oncology. 2022 Sep 23;S0090-8258(22)01822-4.
WEBSITE
Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon
Fokom Domgue J, Pande M, Yu R, Manjuh F, Welty E, Welty T, Elit L, Lopez-Varon M, Rodriguez J, Baker E, Dangou JM, Basu P, Plante M, Lecuru F, Randall T, Starr E, Kamgno J, Foxhall L, Waxman A, Hawk E, Schmeler K, Shete S. Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon. JAMA Netw Open. 2022 Nov 1;5(11):e2240801.
WEBSITE
A Survey-Based Study on Physical Activity Promotion for Individuals with a Current or Past Diagnosis of Cancer in Canada
Smith-Turchyn J, Sabiston CM, Ball E, Mukherjee SD. A Survey-Based Study on Physical Activity Promotion for Individuals with a Current or Past Diagnosis of Cancer in Canada. Curr Oncol. 2022 Dec 13;29(12):9801-9812.
WEBSITE
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study
Mian H, Wildes TM, Vij R, Pianko MJ, Major A, Fiala MA. Blood Cancer Journal. 2023 May;13(1):76.
WEBSITE
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
Mozessohn L, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein R. Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes. JCO Oncology Practice. 2023 April; 19(4) 559-569.
WEBSITE
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Lalani A-KA, Kapoor A, Basappa NS, Bhindi B, Bjarnason GA, Bosse D, Breau RH, Canil CM, Cardenas LM, Castonguay V, Chavez-Munoz C, Chu W, Dudani S, Graham J, Heng DYC, Kollmannsberger C, Lattouf J-B, Morgan S, Reaume MN, Richard PO, Swaminath A, Tanguay S, Wood LA, Lavallée LT. Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement. Canadian Urological Association Journal. 2023 May; 17(5): 154-163
WEBSITE
Competency-Based Medical Education in Canadian Radiation Oncology Residency Training: an Institutional Implementation Pilot Study
Safavi AH, Sienna J, Strang BK, Hann C. Competency-Based Medical Education in Canadian Radiation Oncology Residency Training: an Institutional Implementation Pilot Study. Journal of Cancer Education. 2023 Feb; 38(1) 274-284
WEBSITE
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy
Mohyuddin GR, Chakraborty R, Calip GS, Ascha MS, Wang X, Rubinstein SM, Tuchman S, Costa L, Haaland B, Giri S, Mian H, Fonseca R, Sborov D. Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood Cancer J. 2022 Dec 16;12(12):168. doi: 10.1038/s41408-022-00769-4. PMID: 36526617; PMCID: PMC9758218.
WEBSITE
A Survey of Patient Experience in CML: American and Canadian Perspectives
Hillis C, Flynn KE, Goldman EH, Moreira-Lucas TS, Visentini J, Dorman S, Ballinger R, Byrnes HF, De Palma A, Barbier V, Machado L, Atallah E. A Survey of Patient Experience in CML: American and Canadian Perspectives. Patient Prefer Adherence. 2023 Feb 3;17:331-347.
WEBSITE
Developing a Data and Analytics Platform to Enable a Breast Cancer Learning Health System at a Regional Cancer Center.
Petch J, Kempainnen J, Pettengell C, Aviv S, Butler B, Pond G, Saha A, Bogach J, Allard-Coutu A, Sztur P, Ranisau J, Levine M. Developing a Data and Analytics Platform to Enable a Breast Cancer Learning Health System at a Regional Cancer Center. JCO Clin Cancer Inform. 2023 Mar;7:e2200182
WEBSITE
Generative AI for brain image computing and brain network computing: a review
Gong C, Jing C, Chen X, Pun CM, Huang G, Saha A, Nieuwoudt M, Li HX, Hu Y, Wang S. Generative AI for brain image computing and brain network computing: a review. Front Neurosci. 2023 Jun 13;17:1203104.
WEBSITE
Outcome of carfilzomib/pomalidomide?based regimens after daratumumab?based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis
LeBlanc R, Mian H, Reece D, Su J, Masih-Khan E, Chu M, Jimenez-Zepeda V, Sebag M, Song K, Louzada M, Kotb R, Visram A, White D, Stakiw J, Reiman A, Aslam M, Bergstrom D, Kaedbey R, Gul E, Venner C. Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. Eur J Haematol. 2023 Nov;111(5):815-823.
WEBSITE
Magnetic Resonance Imaging–Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)
Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Machado A, Levental M, Ghai S, Chang SD, Patel C, Kassam Z, Loblaw A, Kebabdjian M, Pond G, Haider MA. Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE). Eur Urol Oncol. 2023 Oct 12:S2588-9311(23)00204-3.
WEBSITE
Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance
Ahmadi E, Wang S, Gouran-Savadkoohi M, Douvi G, Isfahanian N, Tsakiridis N, Faught BE, Cutz JC, Sur M, Chawla S, Pond GR, Steinberg GR, Brown I, Tsakiridis T. Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance. Int J Mol Sci. 2023 Nov 7;24(22):16022.
WEBSITE
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study
Acs B, Leung SCY, Kidwell KM, Arun I, Augulis R, Badve SS, Bai Y, Bane AL, Bartlett JMS, Bayani J, Bigras G, Blank A, Buikema H, Chang MC, Dietz RL, Dodson A, Fineberg S, Focke CM, Gao D, Gown AM, Gutierrez C, Hartman J, Kos Z, Lænkholm A-V, Laurinavicius A, Levenson RM, Mahboubi-Ardakani R, Mastropasqua MG, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Quintayo MA, Rau TT, Reinhard S, Robertson S, Salgado R, Sugie T, van der Vegt B, Viale G, Zabaglo LA, Hayes DF, Dowsett M, Nielsen TO, Rimm DL. Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study. Modern Pathology. 2022 Oct; 35(10): 1362-1369
WEBSITE
Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation
Holloway CMB, Shabestari O, Eberg M, Forster K, Murray P, Green B, Esensoy AV, Eisen A, Sussman J. Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation. Current Oncology. 2022 Jul 28;29(8):5338-5367.
WEBSITE
Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial
Low-Dose Hemibody Radiation, a Treatment Option for Recurrent Prostate Cancer: A Phase 2 Single-Arm Trial. Advances in Radiation Oncology. 2022 Sep 10;8(1):101066.
WEBSITE
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
Choueiri TK, Kluger H, George S, Tykodi SS, Kuzel TM, Perets R, Nair S, Procopio G, Carducci MA, Castonguay V, Folefac E, Lee CH, Hotte SJ, Miller WH Jr, Saggi SS, Lee CW, Desilva H, Bhagavatheeswaran P, Motzer RJ, Escudier B. FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy. J Immunother Cancer. 2022 Nov;10(11):e005780.
WEBSITE
Predicting Severity of Head Collision Events in Elite Soccer Using Preinjury Data: A Machine Learning Approach
Tarzi G, Tarzi C, Saha A, Cusimano MD. Predicting Severity of Head Collision Events in Elite Soccer Using Preinjury Data: A Machine Learning Approach. Clin J Sport Med. 2023 Mar 1;33(2):165-171.